# The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

> **NCT02829502** · PHASE2 · UNKNOWN · sponsor: **Christina Kruuse** · enrollment: 30 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Byetta
- **DRUG:** Normosaline

## Key facts

- **NCT ID:** NCT02829502
- **Lead sponsor:** Christina Kruuse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2023-08
- **Final completion:** 2023-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02829502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02829502, "The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02829502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*